Results 301 to 310 of about 24,787 (310)

Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial

Lancet, The, 2016
Sally E Wenzel, Mario Castro, Jonathan Corren   +2 more
exaly  

Dupilumab for nasal polyposis

Lancet, The, 2020
Brian J Lipworth, Chris RuiWen Kuo
exaly  

Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

New England Journal of Medicine, 2018
Mario Castro, Ian D Pavord, Jorge F Maspero   +2 more
exaly  

Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma

New England Journal of Medicine, 2018
Klaus F Rabe, Parameswaran Nair, Mario Castro   +2 more
exaly  

Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis

New England Journal of Medicine, 2014
Thomas Bieber, Eric Simpson, Marius Ardeleanu   +2 more
exaly  

Dupilumab in Persistent Asthma with Elevated Eosinophil Levels

New England Journal of Medicine, 2013
Sally E Wenzel, Allen Radin
exaly  

Dupilumab: a potential new treatment for severe asthma

Lancet, The, 2016
Kian Fan Chung
exaly  

FDA approves dupilumab for severe eczema

Nature Reviews Drug Discovery, 2017
exaly  

Dupilumab for atopic dermatitis

Lancet, The, 2017
exaly  

Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation

New England Journal of Medicine
Stephanie A Christenson, Nicola A Hanania, Alberto A Papi   +2 more
exaly